Yet another example of a company looking at IGAN Treatments

[Guest guest]

It is so encouraging that there is so much research going on Walt.

Thanks for keeping us abreast of new developments.

In a message dated 11/12/2004 8:39:37 PM Pacific Standard Time,

wcrosby@... writes:

> 11/12/2004 – NephroGenex Inc., which develops treatments for kidney

> diseases using novel molecular profiling technology, said it raised

> $500,000 of seed financing in the form of a promissory note

> convertible to preferred stock. [ full story ]

>

> http://www.nephrogenex.com

>

[Guest guest]

From VentureWire today:

Kidney Disease Co. NephroGenex Gets $500K Seed Round; Raising Series

A

By VentureWire Staff Reporters

11/12/2004 – NephroGenex Inc., which develops treatments for kidney

diseases using novel molecular profiling technology, said it raised

$500,000 of seed financing in the form of a promissory note

convertible to preferred stock. [ full story ]

http://www.nephrogenex.com

[Guest guest]

Thanks for the link! And thanks to everyone else who posted links to

some great articles this week. It's good to see that there is some

budding research out there for us. I've read the articles but with

my goofy ISP thing haven't been able to respond to the group properly.

Amy G.

>

> From VentureWire today:

>

> Kidney Disease Co. NephroGenex Gets $500K Seed Round; Raising

Series

> A

> By VentureWire Staff Reporters

>

> 11/12/2004 – NephroGenex Inc., which develops treatments for kidney

> diseases using novel molecular profiling technology, said it raised

> $500,000 of seed financing in the form of a promissory note

> convertible to preferred stock. [ full story ]

>

> http://www.nephrogenex.com